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Insulin resistance in African Americans. Hypertension and dia- sults in localized alterations in endothelial cell function,
betes mellitus are the leading contributors to end-stage renal including increased permeability to plasma lipoproteins,
disease. African Americans suffer higher rates of renal failure thrombogenesis, attenuation in nitric oxide bioavailabil-as well as other vascular morbidities associated with hyperten-
ity, and vasoconstriction. Abnormalities in endothelialsion and diabetes. Insulin resistance is strongly associated with
cell function are demonstrated in the conditions of ath-hypertension. Insulin resistance is a component of diabetes
and also precedes the clinical expression of type 2 diabetes. erosclerosis, diabetes, hypertension, and tobacco use [3],
The relationship of blood pressure with insulin resistance, or all of which are high risk conditions for cardiovascular
impaired insulin action, occurs in African Americans and can events. Endothelial dysfunction then represents an accel-be detected at young ages prior to the clinical expression of
erated phase of vascular pathology. Insulin resistance,hypertension or diabetes. Through its relationship with hyper-
a condition of impaired insulin action with consequenttension, diabetes, and hyperlipidemia, insulin resistance is asso-
ciated with endothelial dysfunction. The interface of insulin hyperinsulinemia, is present in the clinical disorders
resistance with endothelial dysfunction may begin to explain linked with oxidative stress and endothelial dysfunction.
the role of insulin resistance in vascular and renal pathology.
The potential contribution of insulin resistance to ne-The injury process, subsequent to both hypertension and diabe-
phropathy in African Americans will be discussed.tes, appears to be mediated by alterations tissue regulatory
factors, and include vasoactive peptides such as angiotensin II,
INSULIN RESISTANCE ANDendothelin, and growth factors. Understanding the determi-
nants that up-regulate the aberrant pathways and the early BLOOD PRESSURE
phases of these processes will be necessary to formulate strate-
The mixed metabolic syndrome consisting of obesity,gies to effectively achieve renal protection and reduce the rates
hyperinsulinemia, diabetes (or glucose intolerance), highof renal failure in African Americans.
blood pressure (BP), and dyslipidemia, is strongly associ-
ated with vascular disease [4]. The core component of
this metabolic syndrome is insulin resistance, or impairedVascular diseases, including end-stage renal disease
insulin-mediated glucose utilization, with consequent hy-(ESRD), strokes, and coronary artery disease (CAD),
perinsulinemia [5]. Obesity may cause insulin resistance/are the leading causes of death and disability in African
hyperinsulinemia due to the resistance of adipose tissueAmericans. Although African Americans appear to share
to insulin action. Alternatively, the primary defect maywith Caucasians the same conventional risk factors for
be one of impaired insulin-mediated uptake by periph-vascular disease, there are a paucity of data to explain
the excess prevalence and morbidity in this racial group. eral muscle cells. The resulting hyperinsulinemia may
Both hypertension and diabetes contribute to vascular then lead to obesity due to the growth promoting effects
disease morbidity and mortality, and both of these disor- of insulin. The relationship between insulin resistance
ders occur at disproportionately greater rates in African and hypertension has been well established in African
Americans compared to Caucasians [1]. The expression Americans and other racial groups [6]. However, the
of vascular events is further augmented when hyperten- association of hypertension with insulin resistance is a
sion and diabetes occur together [2]. pathologic conundrum because in normal humans, insu-
The concept of endothelial dysfunction has developed lin has a vasodilator effect, resulting in an increase in
as a model on which to examine the mechanisms and me- blood flow and a decrease in vascular resistance [7].
diators of vascular injury. Pathologic stimuli, such as high Clinical studies on patients with the insulin resistant con-
blood pressure (BP), hyperlipidemia, hyperglycemia, and ditions of obesity and type 2 diabetes have reported a
smoking induce oxidative stress. The oxidative stress re- blunted vasodilator response to insulin infusions [8].
These data support the concept that the condition of
insulin resistance may not be limited to glucoregulatoryKey words: insulin resistance, sodium sensitivity, glucose tolerance,
hypertension, diabetes mellitus, African Americans. action, but also may include vascular endothelial cell re-
sistance to insulin action, and thereby contribute to endo- 2003 by the International Society of Nephrology
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thelial dysfunction. Thus, the hypertension-insulin resis- can lead to a volume dependent pressor effect, which,
transmitted to the renal vasculature, could contribute totance linkage could be due to endothelial dysfunction,
resulting in an imbalance in vasoactive peptides that hyperfiltration. Alternatively, the hyperfiltration may be
due to failure in autoregulation of the renal vasculature.favor vasoconstriction.
An alternative concept to explain insulin resistance Kotchen et al found an increase in glomerular filtration
rate (GFR) in response to norepinephrine infusions amongwith the progression of hypertensive vascular disease is
based on primary changes in peripheral vessels. While hypertensive African Americans, suggesting a reduced
capacity to protect the glomeruli from pressure stressBP elevations per se play a role in the development of
vascular hypertrophy, Folkow proposed that structural [18]. Similarily, Price et al reported a blunted vasocon-
strictor response to angiotensin II infusion in a samplechanges in peripheral vessels could be seminal events
in raising vascular resistance and systemic BP [9]. This of healthy African Americans [19]. These changes were
eliminated following captropril treatment, suggesting anconcept is further described by Julius, who proposed
that it is subjects with increased sympathetic tone and a altered intrarenal renin system in African Americans.
This pattern is consistent with the phenotype of “non-hyperkinetic circulation who progress to chronic hyper-
tension through alterations in vessel structure that in- modulation” [20], a phenotype associated with insulin
resistance.clude hypertrophy of the muscular layer of the vascular
wall and vascular rarefaction [10]. This theory proposes A candidate vasoconstrictor peptide that could be rel-
evant to insulin resistance and renal disease in Africanthat the changes in vascular configuration decrease the
microcirculatory supply to skeletal muscle and increase Americans is endothelin-1 (ET-1). In vitro studies have
found that, in addition to vasoconstriction, ET-1 stimu-the diffusion distance between the vessel and the metab-
olizing cell. As a result of these tissue changes there lates mitogenesis in vascular smooth muscle and mesan-
gial cells, and also stimulates angiotensin II [21]. Insulinwould be a reduction in the delivery of glucose to the
muscle cell, thereby creating a state of relative insulin stimulates ET-1 gene expression, [22] and higher plasma
levels of ET-1 have been reported in clinical conditionsresistance. Despite the competing theories on the causal
relationship between hypertension and insulin resis- of insulin resistance [23]. Plasma ET-1 levels also are re-
ported to be higher in African American men comparedtance, it is possible that the determining aspect is linked
with growth, development, and vascular aging. There is to Caucasian men [24] and in hypertensive African Ameri-
cans compared to hypertensive Caucasians [25]. Basedevidence that the early phase of BP elevation is marked
by sympathetic overactivity [11]. There is also a consis- on these reports and the contribution of ET-1 to regula-
tion of sodium and water balance, Ergul proposed thattent trend in higher BP levels among African Americans
from childhood, through adolescence, into adulthood ET-1 may be turned on in salt-sensitive hypertension and
contribute to renal disease in African Americans [26].[12], and there is a consistent co-segregation of insulin
resistance with higher BP [13]. Thus, it is plausible that
alterations in vascular growth and structure mediate the INSULIN RESISTANCE AND
observed relationships between insulin resistance and GLUCOSE TOLERANCE
BP; with expression of endothelial dysfunction occurring
Insulin resistance is a component of type 2 diabetesas glucose regulation shifts toward diabetes. The various
mellitus, and generally precedes the clinical expressionpathogenic pathways engaged by endothelial dysfunc-
of diabetes. Concurrent hypertension in patients withtion then accelerate the vascular injury.
type 2 diabetes occurs frequently, and when these two
disorders occur within patients, the risk for nephropathy
INSULIN RESISTANCE AND is augmented [2]. It is quite possible that the pathogenic
SODIUM SENSITIVITY mechanisms that mediate vessel and tissue injury are
underway prior to full clinical expression of diabetes orThe role of sodium in blood pressure regulation may
be relevant in African Americans, a group that expresses hypertension. In a cohort of young adult African Ameri-
cans, none of whom were known diabetics, we detectedmore salt sensitivity [14]. Insulin resistance with hyper-
insulinemia is associated with sodium sensitivity [15]. In 28% of the sample with either impaired glucose toler-
ance (IGT) or undetected diabetes based on an oralhealthy young African Americans, we have found that
plasma insulin concentration correlates significantly with glucose tolerance test [27]. When the sample was strati-
fied by glucose tolerance status as normal glucose toler-BP sensitivity to sodium. Both BP sensitivity to sodium
and plasma insulin level predict change in BP over a five ant (NGT), IGT, or diabetic (DM), there was a linear
upward shift in BP as glucose tolerance deterioratedyear interval, suggesting that hyperinsulinemia contrib-
utes to the expression of the sodium sensitivity pheno- from NGT to IGT to DM. The upward linear trend in
BP remained significant after adjustment for obesity.type [16]. Hyperinsulinemia augments renal tubular so-
dium reabsorption [17]. A net gain in sodium balance The measures of insulin sensitivity by insulin clamp also
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demonstrated greater insulin resistance as glucose toler-
ance deteriorated. The rates of obesity were quite high
in this cohort, but consistent with the high rates of obesity
among African Americans. Of note was the observation
that there was no difference in body mass index, particu-
larly among the women, between the NGT and IGT.
Thus, some, but not all, individuals with obesity and hy-
perinsulinemia are vulnerable to the toxic effects of obe-
sity and express the other components of the insulin
resistance syndrome with rising BP, impaired glucose
tolerance, and elevation in plasma lipids. When we exam-
ined urinary albumin excretion as an indicator of tissue
or vessel injury, we found no difference in urinary albu-
min excretion between the normotensive versus the hy-
pertensive subjects. However, the urinary albumin excre-
tion was significantly greater in those with IGT compared Fig. 1. Urinary transforming growth factor- (TGF-) excretion is
presented for cases with normal glucose tolerance (NGT) and casesto NGT regardless of their BP status. These observations
with impaired glucose tolerance (IGT). Overnight urine collectionssuggest that the aberrant mechanisms that mediate tissue represent the baseline and are designated as Pre and urine collections
injury may be operational prior to full clinical expression following the OGTT are designated as Post. Urinary TGF- is presented
as pg/mg creatinine. Data are mean  standard deviation.of disease.
Pathologic characteristics of diabetic nephropathy in-
clude hypertrophy of glomerular and tubular cells, with
thickening of glomerular and tubular membranes and
in the cases with IGT compared to NGT. Although thesubsequent accumulation of extracellular matrix compo-
sample size was quite limited, these few cases indicatenents. In vitro studies have shown that exposure of renal
that renal TGF- activity may be increased in the presencecells to high ambient glucose stimulates hypertrophy and
of mild hyperglycemia (IGT) and that, among IGT, aproduction of collagen Types I and IV in proximal tubu-
further increase in TGF- excretion can be detected fol-lar and mesangial cells. The outcome of this process is the
lowing an OGTT. More extensive investigations will becharacteristic accumulation of excess matrix observed in
necessary to confirm these preliminary observations. Ifdiabetic nephropathy [28]. Transforming growth factor-
confirmed the findings would indicate that even modestbeta (TGF-) is a tissue cytokine with multiple fibrino-
levels of relative hyperglycemia along with modest levelsgenic properties. Sharma and Ziyadeh [29] and others
of BP elevation could impose sufficient oxidative stress tohave demonstrated increased levels of TGF- in kidney
impose endothelial dysfunction. The consequent up-regu-cells of genetically diabetic animals as well as in strepto-
lation of tissue factors such as ET-1, angiotensin II, andzotocin-induced diabetic animals. The common factor
TGF-would then augment tissue and vessel injury. Insu-that directs an increase in TGF- activity in the experi-
lin resistance appears to be an underlying platform frommental studies has been hyperglycemia. There is also
which these processes emanate.some clinical evidence that this tissue cytokine may con-
tribute to renal pathology in humans. Up-regulation of
TGF- activity has been reported to be associated with SUMMARY
renal alterations in patients with hypertension [30] and
Insulin resistance, as a syndrome, occurs in Africanin patients with diabetes [31]. Although the evidence to
Americans as well as other ethnic groups. Among Afri-date suggests that hyperglycemia is involved in up-regu-
can Americans there is a consistent relationship of insu-lation of TGF- activity, the necessary level of hypergly-
lin resistance with BP, which is present from a young agecemia and the extent to which TGF- can initiate renal
and remains significant despite adjustment for adiposity.tissue injury in humans has not yet been determined.
There is a linear upward trend in BP as glucose toleranceWe explored this question in a pilot study on our cohort
deteriorates. Insulin resistance is linked with hyperten-of young adult African Americans. Timed urine samples
sion and diabetes, two conditions that occur at dispro-were collected overnight and again following an oral glu-
portionately high rates among African Americans. Ac-cose tolerance test (OGTT). The samples were assayed
cording to the oxidative stress concept, the barotraumafor creatinine and TGF-. TGF- excretion was calculated
from hypertension and the hyperglycemia of diabeteson eight subjects with NGT and nine cases with IGT.
induce oxidative stress to the tissue. The free radicalsFigure 1 provides the TGF- excretion, expressed as pg/mg
generated then disrupt the normal regulatory balancecreatinine in this small sample. Urinary TGF- excretion
at baseline (pre) and following OGTT (post) was higher of vascular endothelial cells. Endothelial dysfunction is
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